Pharmacogenomics on gastric cancer

Cancer Biology and Therapy

Volumn 3, Issue 6, 2004, Pages 566-567

  Katoh, Masuko ^a   Katoh, Masaru ^b  

^a M&M Medical BioInformatics   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

ATP binding cassette transporter; Drug resistance; Gastric cancer; Gene therapy; Membrane trafficking; Monoubiquitination; Oncogenomics; RNAi; TSG101

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; IRINOTECAN; PACLITAXEL; SMALL INTERFERING RNA; TUMOR SUSCEPTIBILITY GENE 101 PROTEIN; VINCRISTINE; DNA BINDING PROTEIN; LEUCINE ZIPPER PROTEIN; TRANSCRIPTION FACTOR;

BIOINFORMATICS; CANCER CELL; DISEASE SEVERITY; DNA MICROARRAY; ENDOSCOPY; FUNCTIONAL ASSESSMENT; GASTRECTOMY; GENOME; GENOTYPE; HUMAN; MULTIDRUG RESISTANCE; PATIENT; PHARMACOGENETICS; PHENOTYPE; PROTEIN EXPRESSION; REVIEW; SIDE EFFECT; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; TRANSCRIPTION REGULATION; UPREGULATION; DOWN REGULATION; DRUG RESISTANCE; GENETICS; METABOLISM; NOTE; STOMACH TUMOR;

ANTINEOPLASTIC AGENTS; DNA-BINDING PROTEINS; DOWN-REGULATION; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; LEUCINE ZIPPERS; PHARMACOGENETICS; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 21644467144     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.3.6.936     Document Type: Review

References (31)

1. Pisani P, Bray F and Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 2002; 97:72-81.
2. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965; 64:31-49.
3. Katoh M, Terada M. Oncogenes and tumor suppressor genes. In: Nishi M ed. Gastric cancer. Tokyo:Splinger-Verlag, 1993:196-208.
4. Katoh M, Katoh M. MGC9753 gene, located within PPP1R1B-STARD3-ERBB2-GRB7 amplicon on human chromosome 17q12, encodes seven-transmembrane receptor with extracellular six-cystein domain. Int J Oncol 2003; 22:1369-74.
5. Katoh M, Katoh M. Evolutionary recombination hotspot around GSDML-GSDM locus is closely linked to oncogenomic recombination hotspot around PPP1R1B-ERBB2-GRB7 amplicon. Int J Oncol 2004; 24:757-63.
6. Katoh M, Katoh M. FGFR2 and WDR11 are neighboring oncogene and tumor suppressor gene located on human chromosome 10q26. Int J Oncol 2003; 22:1155-9.
7. Katoh M, Katoh M. Recombination cluster around FGFR2-WDR11-HTPAPL locus on human chromosome 10q26. Int J Mol Med 2003; 11:579-83.
8. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, et al. Identification of FAP locus genes from chromosome 5q21. Science 1991; 253:661-5.
9. Nishisho I, Nakamura Y, Miyoshi Y, Mild Y, Ando H, Horii A, et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991; 253:665-9.
10. Roninson IB, Chin JE, Choi KG, Gros P, Housman DE, Fojo A, et al. Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci USA 1986; 83:4538-42.
11. Katoh M, Hirai M, Sugimura T, Terada M. Cloning, expression and chromosomal localization of WNT13, a novel member of the WNT gene family. Oncogene 1996; 13: 873-6.
12. Katoh M. Paradignshift in gene-finding method: From bench-top approach to desk-top approach. Int J Mol Med 2002; 10:677-82.
13. Pollack JR, Sorlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE, et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci USA 2002; 99:12963-8.
14. Redon R, Hussenet T, Bour G, Caulee K, Jost B, Muller D, et al. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 2002; 62:6240-5.
15. Hasegawa S, Furukawa Y, Li M, Satoh S, Kato T, Watanabe T, et al. Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes. Cancer Res 2002; 62:7012-7.
16. Katoh M, Katoh M. CLDN23 gene, frequently down-regulated in intestinal-type gastric cancer, is a novel member of CLAUDIN gene family. Int J Mol Med 2003; 11:683-9.
17. Katoh M, Katoh M. IGSF11 gene, frequently up-regulated in intestinal-type gastric cancer, encodes adhesion molecule homologous to CXADR, FLJ22415 and ESAM. Int J Oncol 2003; 23:525-31.
18. Katoh M, Katoh M. Identification and characterization of human BCL9L gene and mouse Bcl9l gene in silico. Int J Mol Med 2003; 12:643-9.
19. Ohnishi Y, Tanaka T, Ozaki K, Yamada R, Suzuki H, Nakamura Y. A high-throughput SNP typing system for genome-wide association studies. J Hum Genet 2001; 46:471-7.
20. Haga H, Yamada R, Ohnishi Y, Nakamura Y, Tanaka T. Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190, 562 genetic variants in the human genome. Single nucleotide polymorphism. J Hum Genet 2002; 47:605-10.
21. Berardi R, Scartozzi M, Romagnoli E, Antognoli S, Cascinu S. Gastric cancer treatment: a systematic review. Oncol Rep 2004; 11:911-6.
22. Allikmets R, Gerrard B, Huchinson A, Dean M. Characterization of the human ABC superfamily: isolation and mapping of new genes using the expressed esquence tags database. Hum Mol Genet 1996; 5:1649-55.
23. Zhao Y, You H, Liu F, An H, Shi Y, Yu Q, Fan D. Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells. Cancer Lett 2002; 185:211-8.
24. Kang HC, Kim IJ, Park JH, Shin Y, Ku JL, Jung MS, et al. Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays. Clin Cancer Res 2004; 10:272-84.
25. Shen H, Pan Y, Han Z, Hong L, Liu N, Han S, et al. Reversal of multidrug resistance of gastric cancer cells by downregulation of TSG101 with TSG101 SiRNA. Cancer Biol Ther 2004; 3:e28-e32.
26. Li L, Li X, Francke U, Cohen SN. The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer. Cell 1997; 88: 143-54.
27. Lee MP, Feinberg AP. Aberrant splicing but not mutations of TSG101 inhuman breast cancer. Cancer Res 1997; 57:3131-4.
28. Liu RT, Huang CC, You HL, Chou FF, Hu CC, Chao FP, et al. Overexpression of tumor suppressor gene TSG101 in human papillary thyroid carcinomas. Oncogene 2002; 21:4830-7.
29. Dupre S, Volland C, Haguenauer-Tsapis R. Membrane transport: ubiquitylation in endosomal sorting. Cuu Biol 2001; 11:R923-4.
30. Martin-Serrano J, Zang T, Bieniasz PD. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat Med 2001; 7: 1313-9.
31. Burgdorf S, Leister P, Scheidtmann KH. TSG101 interacts with apoptosis-antagonizing transcription factor and enhances androgen receptor-mediated transcription by promoting its monoubiquitination. J Biol Chem 2004; 279:17524-34.